---
http_interactions:
- request:
    method: post
    uri: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?api_key=Settings.PUBMED.API_KEY&db=pubmed&retmode=xml
    body:
      encoding: UTF-8
      string: "&id=&id=23684686"
    headers:
      User-Agent:
      - stanford-library-sul-pub
      Accept:
      - "*/*"
      Accept-Encoding:
      - gzip,deflate
      Date:
      - Wed, 18 Oct 2023 03:13:02 GMT
      Content-Type:
      - application/x-www-form-urlencoded
      Cookie:
      - ncbi_sid=19C31FA26B1E0874_2C23SID
  response:
    status:
      code: 200
      message: OK
    headers:
      Date:
      - Wed, 18 Oct 2023 03:13:02 GMT
      Server:
      - Finatra
      Strict-Transport-Security:
      - max-age=31536000; includeSubDomains; preload
      Content-Security-Policy:
      - upgrade-insecure-requests
      Referrer-Policy:
      - origin-when-cross-origin
      Ncbi-Sid:
      - 19C31FA26B1E0874_2C23SID
      Ncbi-Phid:
      - 939B7494D675AB450000289C59AF6737.1.1.m_3
      Content-Type:
      - text/xml; charset=UTF-8
      Cache-Control:
      - private
      Content-Encoding:
      - gzip
      X-Ratelimit-Limit:
      - '10'
      X-Ratelimit-Remaining:
      - '6'
      Access-Control-Allow-Origin:
      - "*"
      Access-Control-Expose-Headers:
      - X-RateLimit-Limit,X-RateLimit-Remaining
      Set-Cookie:
      - ncbi_sid=19C31FA26B1E0874_2C23SID; domain=.nih.gov; path=/; expires=Fri, 18
        Oct 2024 03:13:03 GMT
      X-Ua-Compatible:
      - IE=Edge
      X-Xss-Protection:
      - 1; mode=block
      Transfer-Encoding:
      - chunked
    body:
      encoding: UTF-8
      string: |-
        <?xml version="1.0" ?>
        <!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
        <PubmedArticleSet>
        <PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23684686</PMID><DateCompleted><Year>2013</Year><Month>10</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-3597</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>6</Issue><PubDate><Year>2013</Year><Month>Aug</Month><Day>06</Day></PubDate></JournalIssue><Title>Journal of the American College of Cardiology</Title><ISOAbbreviation>J Am Coll Cardiol</ISOAbbreviation></Journal><ArticleTitle>Subtle post-procedural cognitive dysfunction after atrial fibrillation ablation.</ArticleTitle><Pagination><StartPage>531</StartPage><EndPage>539</EndPage><MedlinePgn>531-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacc.2013.03.073</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0735-1097(13)01882-2</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study sought to determine whether post-operative neurocognitive dysfunction (POCD) occurs after ablation for atrial fibrillation (AF).</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Ablation for AF is a highly effective strategy; however, the risk of transient ischemic attack and stroke is approximately 0.5% to 1%. In addition, magnetic resonance imaging studies report a 7% to 14% prevalence of silent cerebral infarction. Whether cerebral ischemia results in POCD after ablation for AF is not well established.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study included 150 patients; 60 patients undergoing ablation for paroxysmal atrial fibrillation (PAF), 30 patients undergoing ablation for persistent atrial fibrillation (PeAF), and 30 patients undergoing ablation for supraventricular tachycardia (SVT) were compared with&#xa0;a matched nonoperative control group of patients with AF awaiting radiofrequency ablation (n&#xa0;= 30). Eight neuropsychological tests were administered at baseline and at 2 days and 90 days post-operatively. The tests were administered at the same&#xa0;time&#xa0;points to the nonoperative control group. The reliable change index was used to calculate POCD.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The prevalences of POCD at day 2 post-procedure were 28% in patients with PAF, 27% in patients with PeAF, 13% in patients with SVT, and 0% in control patients with AF (p&#xa0;= 0.007). At day 90, the prevalences of POCD were 13% in patients with PAF, 20% in patients with PeAF, 3% in patients with SVT, and 0% in control patients with AF (p&#xa0;= 0.03). When analyzing the 3 procedural groups together, 29 of 120 patients (24%) manifested POCD at day 2 and 15 of 120 patients (13%) at day 90 post-procedure (p&#xa0;= 0.029). On univariate analysis, increasing left atrial access time was associated with POCD at day 2 (p&#xa0;= 0.04) and day 90 (p&#xa0;= 0.03).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Ablation for AF is associated with a 13% to 20% prevalence of POCD in patients with AF at long-term follow-up. These results were seen in a patient population with predominant CHADS2 (Congestive heart failure, Hypertension, Age&#xa0;&#x2265;75 years, Diabetes mellitus, previous Stroke/transient ischemic attack) scores of 0 to 1, representing the majority of patients undergoing ablation for AF. The long-term implications of these subtle changes require further study.</AbstractText><CopyrightInformation>Copyright &#xa9; 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Medi</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Royal Melbourne Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evered</LastName><ForeName>Lisbeth</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Silbert</LastName><ForeName>Brendan</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Teh</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Halloran</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Morton</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Kistler</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Kalman</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Coll Cardiol</MedlineTA><NlmUniqueID>8301365</NlmUniqueID><ISSNLinking>0735-1097</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Am Coll Cardiol. 2013 Aug 6;62(6):540-2</RefSource><PMID Version="1">23684681</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017115" MajorTopicYN="Y">Catheter Ablation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013617" MajorTopicYN="N">Tachycardia, Supraventricular</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACT</Keyword><Keyword MajorTopicYN="N">AF</Keyword><Keyword MajorTopicYN="N">CERAD</Keyword><Keyword MajorTopicYN="N">CHADS(2)</Keyword><Keyword MajorTopicYN="N">CI</Keyword><Keyword MajorTopicYN="N">Congestive heart failure, Hypertension, Age&#xa0;&#x2265;75 years, Diabetes mellitus, previous Stroke/transient ischemic attack</Keyword><Keyword MajorTopicYN="N">Consortium to Establish a Registry for Alzheimer's Disease</Keyword><Keyword MajorTopicYN="N">IQ</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">OR</Keyword><Keyword MajorTopicYN="N">PAF</Keyword><Keyword MajorTopicYN="N">POCD</Keyword><Keyword MajorTopicYN="N">PeAF</Keyword><Keyword MajorTopicYN="N">RCI</Keyword><Keyword MajorTopicYN="N">RFA</Keyword><Keyword MajorTopicYN="N">SVT</Keyword><Keyword MajorTopicYN="N">ablation</Keyword><Keyword MajorTopicYN="N">activated clotting time</Keyword><Keyword MajorTopicYN="N">atrial fibrillation</Keyword><Keyword MajorTopicYN="N">confidence interval</Keyword><Keyword MajorTopicYN="N">intelligence quotient</Keyword><Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">neurocognitive dysfunction</Keyword><Keyword MajorTopicYN="N">odds ratio</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword><Keyword MajorTopicYN="N">paroxysmal atrial fibrillation</Keyword><Keyword MajorTopicYN="N">persistent atrial fibrillation</Keyword><Keyword MajorTopicYN="N">post-operative cognitive dysfunction</Keyword><Keyword MajorTopicYN="N">radiofrequency ablation</Keyword><Keyword MajorTopicYN="N">reliable change index</Keyword><Keyword MajorTopicYN="N">supraventricular tachycardia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23684686</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2013.03.073</ArticleId><ArticleId IdType="pii">S0735-1097(13)01882-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>
  recorded_at: Wed, 18 Oct 2023 03:13:03 GMT
recorded_with: VCR 6.2.0
